| name | managing-bariatric-surgery-pathways |
| description | Structures bariatric surgery evaluation with insurance requirements, preoperative optimization, and post-surgical nutrition protocols. Use when evaluating bariatric candidates, documenting insurance criteria, or managing post-bariatric care. |
| tags | ["management","surgery","surgical","valuation"] |
| metadata | {"author":"casemark","practice_areas":["General Surgery","Surgical Subspecialties"],"document_types":["Management Report"],"skill_modes":["Management","Coordination"]} |
Managing Bariatric Surgery Pathways
Structures bariatric surgery evaluation with insurance requirements, preoperative optimization, and post-surgical nutrition protocols.
Why This Skill Exists
Bariatric surgery is the most effective long-term treatment for morbid obesity and its metabolic comorbidities. The ASMBS/IFSO 2022 updated guidelines expanded eligibility to BMI ≥35 regardless of comorbidities, or BMI 30-34.9 with metabolic disease. Despite this, bariatric surgery is the most heavily gatekept surgical procedure in the US healthcare system — insurance companies require extensive preoperative documentation including 3-7 months of supervised weight management, psychological evaluation, nutritional counseling, and documentation of comorbidity severity. Incomplete documentation is the primary reason for insurance denials.
MBSAQIP (Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program) accreditation requires standardized patient evaluation, multidisciplinary team involvement, and long-term follow-up data collection. Bariatric programs that fail to track outcomes lose accreditation and face significant reputational and financial consequences. This skill structures the complete bariatric pathway from initial evaluation through long-term postoperative management, ensuring both clinical excellence and insurance/accreditation compliance.
Checkpoint A: Pre-Draft Intake (Mandatory)
- What is the patient's current BMI and highest documented BMI? Default: [VERIFY]
- What obesity-related comorbidities are documented (T2DM, HTN, OSA, NASH, GERD, OA, etc.)? Default: [VERIFY]
- What prior weight loss attempts have been made (diet, exercise, medications, programs)? Default: [VERIFY]
- What insurance plan does the patient have, and what are its specific bariatric surgery requirements? Default: [VERIFY — contact insurance for policy]
- Has the patient completed or started a supervised weight management program? Default: not yet started
- Has psychological evaluation been completed? Default: no
- Does the patient have a history of substance abuse? Default: no
- What procedure is being considered (sleeve gastrectomy, Roux-en-Y gastric bypass, SADI-S, revision)? Default: to be determined after evaluation
Documents to Request
- Insurance policy bariatric surgery requirements (letter of medical necessity template)
- Prior weight loss program documentation (physician-supervised diet records)
- Psychological evaluation report
- Nutrition consultation records
- Sleep study results (if OSA suspected or documented)
- Endocrine evaluation (TSH, cortisol if clinically indicated)
- Upper GI endoscopy or UGI series (per ASMBS guidelines)
- MBSAQIP data collection forms
- Current medication list (especially diabetes, HTN, psych medications)
Step 1: Patient Eligibility Assessment
NIH/ASMBS Criteria for Bariatric Surgery
| Criterion | Requirement | Documentation |
|---|
| BMI ≥40 | Morbid obesity without comorbidities required | Height and weight with date (minimum 2 documented BMI measurements) |
| BMI 35-39.9 | With at least one obesity-related comorbidity | Documented comorbidity with treatment records |
| BMI 30-34.9 | With metabolic disease (T2DM, per 2022 ASMBS/IFSO update) | Documented T2DM with A1c, medication history |
| Failed conservative therapy | Prior attempts at weight loss documented | 6+ months of documented diet/exercise/behavioral modification |
| Age | Generally 18-65 (some programs evaluate 65+) | Birth date |
| Psychological readiness | Evaluated by mental health professional | Formal psychological evaluation report |
Comorbidity Documentation
Document each comorbidity with objective evidence:
| Comorbidity | Required Documentation | Measurement |
|---|
| Type 2 Diabetes | A1c, fasting glucose, medication list, duration | A1c ≥6.5% or on antidiabetic medication |
| Hypertension | BP readings, medication list | BP >130/80 on ≥2 occasions or on antihypertensive |
| OSA | Polysomnography (sleep study) with AHI | AHI ≥5 (mild), ≥15 (moderate), ≥30 (severe) |
| NASH/NAFLD | Liver function tests, imaging, possible biopsy | Elevated ALT, steatosis on imaging |
| GERD | Symptom documentation, PPI use, possible pH study | Endoscopy may be required for procedure selection |
| Osteoarthritis | Imaging, functional limitation documentation | Weight-bearing joint involvement |
| Depression | PHQ-9, treatment records | Active treatment, medication list |
Step 2: Insurance Authorization Process
Common Insurance Requirements (vary by plan)
| Requirement | Typical Standard | Documentation Needed |
|---|
| Letter of medical necessity | Written by bariatric surgeon | Template with BMI, comorbidities, failed treatments, surgical plan |
| Supervised weight management | 3-7 consecutive months of physician visits | Monthly visit notes with weight, diet counseling, exercise plan |
| Nutritional evaluation | 1-2 sessions with registered dietitian | RD assessment with dietary history and education plan |
| Psychological evaluation | Completed by licensed psychologist/psychiatrist | Standardized report addressing motivation, comprehension, substance abuse, eating disorders |
| Sleep study | If OSA suspected | Polysomnography report |
| Cardiac clearance | If significant cardiac history | Cardiology note |
| Documentation of comorbidities | Objective evidence for each | Lab results, imaging, specialist notes |
| Primary care clearance | Medical clearance letter | PCP letter confirming patient is suitable for surgery |
Letter of Medical Necessity Template Components
- Patient demographics and BMI history (highest, current, duration of obesity)
- Complete list of obesity-related comorbidities with objective evidence
- History of failed conservative weight loss attempts with specifics
- Current medications required for obesity-related conditions
- Proposed surgical procedure with rationale
- Expected outcomes (comorbidity resolution rates specific to the proposed procedure)
- Surgeon credentials and program MBSAQIP accreditation status
- References to ASMBS/NIH consensus guidelines supporting surgical eligibility
Step 3: Preoperative Optimization
Medical Clearance Workup
| Test | Purpose | When to Order |
|---|
| CBC, BMP, LFTs | Baseline labs, screen for liver disease | All patients |
| A1c | Diabetes status | All patients |
| TSH | Rule out hypothyroidism as weight contributor | All patients |
| Lipid panel | Cardiovascular risk baseline | All patients |
| Iron studies, B12, folate, vitamin D, thiamine | Baseline nutritional status | All patients (especially for bypass) |
| Cortisol or dexamethasone suppression test | Rule out Cushing's syndrome | If clinical suspicion |
| Polysomnography | Screen for OSA | All patients (unless recently completed) |
| EGD (upper endoscopy) | Screen for H. pylori, Barrett's, hiatal hernia | Recommended for all; mandatory before bypass |
| UGI series | Anatomy assessment | Some programs; alternative to EGD |
| Echocardiogram | Cardiac function | If cardiac symptoms, OSA, or pulmonary HTN suspected |
Preoperative Targets
- A1c <8% (ideally <7%) for elective surgery
- CPAP compliance documented if OSA (≥4h/night, ≥70% of nights for 30 days)
- Smoking cessation ≥6 weeks (cotinine testing may be required)
- Alcohol cessation documented
- Weight loss of 5-10% of excess body weight (liver shrinkage diet for 2-4 weeks preop) — reduces liver volume and improves surgical access
Step 4: Procedure Selection
Comparison of Common Bariatric Procedures
| Factor | Sleeve Gastrectomy (SG) | Roux-en-Y Gastric Bypass (RYGB) | SADI-S/DS |
|---|
| Mechanism | Restriction | Restriction + malabsorption | Restriction + significant malabsorption |
| Expected %EWL at 5 yr | 55-65% | 65-75% | 70-80% |
| T2DM remission rate | 60-70% | 80-85% | 85-95% |
| Operative time | 60-90 min | 90-150 min | 120-180 min |
| Nutritional deficiency risk | Low-moderate | Moderate | High |
| GERD impact | May worsen | Resolves (preferred if GERD present) | Variable |
| Surgical complexity | Low | Moderate | High |
| Revision rate | 5-15% (inadequate weight loss, GERD) | 5-10% | <5% |
Key procedure selection factors:
- GERD or Barrett's esophagus → RYGB preferred (SG may worsen)
- BMI >50 → Consider RYGB or SADI-S for greater expected weight loss
- Medication absorption concerns → SG preferred (no bypass of absorption sites)
- Prior abdominal surgery with hostile abdomen → SG preferred (simpler operation)
- T2DM as primary indication → RYGB or SADI-S (higher metabolic resolution rates)
Step 5: Postoperative Nutrition and Long-Term Follow-Up
Postoperative Diet Progression
| Phase | Timeframe | Allowed | Volume |
|---|
| Phase 1 — Clear liquids | POD 0-1 | Water, broth, sugar-free gelatin | 1 oz Q15 min |
| Phase 2 — Full liquids | Weeks 1-2 | Protein shakes, strained soups, yogurt drinks | 2-4 oz Q30 min |
| Phase 3 — Pureed | Weeks 3-4 | Pureed protein sources, soft scrambled eggs | 4-6 oz per meal |
| Phase 4 — Soft foods | Weeks 5-8 | Ground meats, soft fish, cooked vegetables | 4-6 oz per meal |
| Phase 5 — Regular | Week 8+ | All foods tolerated; avoid carbonation, high sugar | 4-8 oz per meal |
Lifetime Supplementation (procedure-dependent)
| Supplement | SG | RYGB | SADI-S/DS |
|---|
| Multivitamin with iron | 1 daily | 2 daily | 2 daily |
| Calcium citrate + Vitamin D | 1200 mg + 3000 IU daily | 1500 mg + 3000 IU daily | 1800 mg + 5000 IU daily |
| Vitamin B12 | 500 mcg sublingual daily or 1000 mcg IM monthly | Same | Same |
| Iron (menstruating women) | 45-65 mg elemental daily | Same | Same |
| Fat-soluble vitamins (A, D, E, K) | Standard MVI | Standard MVI | Additional supplementation required |
| Thiamine | As needed | As needed | Routine |
MBSAQIP Follow-Up Schedule
| Timeframe | Visit | Labs |
|---|
| 2 weeks | Wound check, diet progression | — |
| 6 weeks | Weight, diet, activity assessment | — |
| 3 months | Weight, comorbidity assessment, diet compliance | CBC, BMP, nutritional labs |
| 6 months | Weight, comorbidity resolution documentation | Nutritional labs, A1c |
| 12 months | Weight nadir assessment, comorbidity status | Complete nutritional panel, A1c, lipids |
| Annually (lifelong) | Weight, nutrition, comorbidity status | Annual nutritional labs |
Checkpoint B: Post-Draft Alignment (Mandatory)
- Does the patient meet NIH/ASMBS eligibility criteria with documented BMI and comorbidities?
- Is the insurance authorization complete with all required elements (supervised weight management, psych eval, nutritional eval)?
- Is the procedure selection documented with rationale addressing patient-specific factors (GERD, BMI, T2DM)?
- Is the preoperative optimization complete (A1c target, CPAP compliance, liver shrinkage diet)?
- Is the postoperative nutrition and follow-up plan documented per MBSAQIP requirements?
Quality Audit
Guidelines
- Never proceed to surgery without complete insurance authorization — retrospective denial after a bariatric procedure creates catastrophic revenue loss and patient financial burden.
- The supervised weight management period must be consecutive and documented monthly. A gap of >30 days between visits may reset the clock per most insurance policies.
- EGD is strongly recommended by ASMBS for all bariatric patients and is mandatory before Roux-en-Y gastric bypass. H. pylori must be treated before surgery. Barrett's esophagus is a relative contraindication to sleeve gastrectomy.
- Psychological evaluation must address substance abuse history, binge eating disorder, psychiatric stability, and informed understanding of the lifelong dietary and lifestyle changes required. Active untreated substance abuse or bulimia are contraindications.
- Lifetime nutritional supplementation is non-negotiable, especially after bypass procedures. Thiamine deficiency can cause irreversible Wernicke encephalopathy, and calcium/vitamin D deficiency leads to metabolic bone disease.
- MBSAQIP requires long-term follow-up data. Programs that lose patients to follow-up jeopardize accreditation. Document follow-up compliance rates and implement outreach for patients overdue for visits.
- For patients with BMI 30-34.9, the 2022 ASMBS/IFSO update supports surgery for metabolic disease — but insurance coverage for this population remains inconsistent. Document the guideline citation in the letter of medical necessity.
